Detalhe da pesquisa
1.
Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma.
Br J Cancer;
122(4): 506-516, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31839677
2.
RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.
Br J Cancer;
115(10): 1193-1200, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27711083
3.
PACMEL: a phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel.
Eur J Cancer;
51(3): 359-66, 2015 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25542057